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1. Introduction 
The sleep-wake rhythms cycle coincides with the solar 24-hour schedule. Most adult 
subjects in nontropical areas are comfortable with 6.5 to 8.0 hours of daily sleep, taken in a 
single period. It is known that normal sleep consists of four to six behaviourally and 
electrophysiologically (EEG) defined cycles. Sleep is divided in two main types:  REM (rapid 
eye movements) sleep and non-REM sleep. In the general population, sleep disorders are 
common and usually associated with some illness, psychological and social disturbances. 
Insomnia as the most common sleep disorder is most often the consequence of psychological 
disturbances. It is characterized by the inability to fall asleep quickly. Sleepwalking, night 
terrors and nightmares are parasomnias which often reflect significant stress or 
physiopathology. Restless legs syndrome and periodic limb movements are a type of motor 
disorders. Restless legs usually occur before sleep onset, while periodic limb movements can 
fragment the sleep. Transient sleep disturbances are mostly associated with variety of 
factors including stress, life changes, shift work, jet lag, and some acute health disorders. 
The most popular drugs, such as alcohol, nicotine and caffeine, can adversely affect the 
quality and quantity of sleep (Hornyak et al., 2006; Lee & Douglass, 2010; Pinel, 2009; 
Vgontzas et al., 2010).    
Occupational exposure to heavy metals, such as cadmium, lead, manganese and mercury, 
was very frequent in the 20th century. Many epidemiological studies show that these heavy 
metals can cause serious functional disability among exposed workers (World Health 
Organization [WHO], 1980). Inorganic lead, manganese and inorganic-elemental mercury 
(Hg) exposure can, among others, cause neurotoxic effects with a typical, but different, 
clinical picture associated with sleep disorder. 
Hg a silvery-white liquid metal is quite attractive and very widespread which, despite 
being highly toxic, was used by humans as a medicine for thousands of years. We shall 
discuss its neurotoxic effects and the sleep disorders it can cause at increased occupational 
exposure. Hg was first described by Aristotle in the 4th century A.D., and the alchemist’s 
concept of Hg leaned on his system of natural phenomena, which dominated all of science 
until the 17th century. For this reason Hg was attributed with all those qualities of nature 
that accelerate development, growth and maturation. The famous Arabian physician 
Avicena, who was active in the 11th century, wrote that Hg vapours cause paralysis, tremor 
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and frequent limb spasms. In Columbus’ time began to be used to treat syphilis. The use of 
its compounds was still widespread in the United States in the 19th century, and was among 
others also used to treat depression (Goldwater, 1972). The popularity of Hg at the time was 
considerable, for even President Abraham Lincoln found relief for his health problems in a 
pharmacy-prepared drug called “blue pills”, which contained elementary Hg (Hirschhorn 
et al., 2001). Various, mostly organic Hg compounds were still widely used in the 20th 
century, and even to a smaller extent today (Clarkson & Magos, 2006). 
The Roman historian Pliny speaks of the first occupational Hg intoxications – 
hydrargyrismis, or mercurialism, in slaves who mined and smelted Hg ore for several 
centuries in the Sisapo-Almaden mine. Occupational exposure to Hg did not receive any 
noticeable attention until the 15th century, when Ulrich Ellenenborg described occupational 
exposure for the first time in his book, which was published posthumously in 1524. In a very 
extensive work entitled »The morbis artificum diatribe« (1700), Bernardo Ramazzini 
presented several occupational illnesses, among which he also described occupational 
intoxications with Hg vapours (Goldwater, 1972). In the 16th century, several physicians 
described the symptoms and signs of Hg intoxication in miners of the Idrija Mercury Mine, 
the most famous among them being Theophrastus von Hohenheim, otherwise known as 
Paracelsus, and Pierandreia Mattioli, a reputed botanist and physician who worked in the 
town of Gorica at the time (1544). 
In his book Von der Bergsucht und anderen Krankheiten, published in 1527, Paracelsus 
described the serious condition of sick miners whom he had met during his visit to the Idrija 
Mine: “All the people who live there are deformed and paralyzed, asthmatic and benumbed, 
without any hope of ever getting well” (Lesky, 1956, p. 8). Hg intoxication in mercury 
miners of the Idrija Mercury Mine was well-described by Joannes Antonius Scopoli, the first 
physician appointed to the Idrija Mercury Mine in 1754. Along with the symptoms of Hg 
intoxication observed in miners, he also described their personality traits as well the 
characteristics of sleep disorders that usually appear in Hg intoxication. Sleep disorders 
were also mentioned in the monographs on inorganic mercury published by WHO (1976, 
1991) and the Agency for Toxic Substances and Disease Registry [ATSDR] (1999).  
The observations of J. A. Scopoli in the 18th  century, our observations of workers exposed to 
Hg in the Idrija Mercury Mine, as well as certain biochemical interactions of Hg in central 
nervous system (CNS) that were studied by many researchers in the late 20th and early 21st 
centuries, help to throw light on those biochemical effects of Hg in CNS that could 
hypothetically disturb the regulation of sleep and cause the sleep disorders occurring in 
occupational intoxications or increased Hg absorption in exposed miners and smelters. In 
this chapter, we shall briefly present the subjective characteristics of sleep disorder observed 
in occupational Hg intoxication and increased absorption, the interaction of Hg in the 
body and its toxic effects in the CNS, the basic neurobiological and biochemical 
characteristics of sleep-wake cycles and, finally, its hypothetical interactions with Hg. 
2. Sleep disorder in occupational exposure to Hg vapours 
J. A. Scopoli presented his knowledge on occupational Hg exposure of miners and smelters in 
the Idrija Mercury Mine in his book entitled DE HYDRARGYRO IDRIENSI TENTAMINA 
Phisico – Chimico – Medica, which was printed in Venice in 1761, and reprinted in 1771. In the 
third part of this book, De Morbis Fossorum Hydrargyri, he presents an in-depth description of 
www.intechopen.com
 
Elemental Mercury Exposure and Sleep Disorder 
 
49 
the symptoms of mercury intoxication - mercurialism among pit and smeltery workers. He 
classifies mercurialism according to those symptoms that are the most pronounced in the 
disease pattern. Scopoli describes acute, sub-acute and chronic Hg intoxication appearing 
during work in the smelting plant and in the pit, in poorly ventilated sites with native ore 
where, according to our present-day knowledge (Kobal, 1994), mercury vapour concentrations 
were extremely high. Among the symptoms accompanying chronic intoxication, Scopoli 
mentions changes in some personality traits, such as bad temper, irritability and sadness, as 
well as sleep disorder. “…somnus inquietus, somnia terrifica, artuum agitatio…” are the key 
words which Scopoli uses (1771, p. 80). He finds that mercury intoxication is accompanied by 
restless sleep, terrible dreams with nightmares, sleep terrors, and strange, periodic contractile 
movements of the legs (Kobal & Kobal-Grum, 2010). The reputed clinical toxicologist, Adolph 
Kussmaul, presented in his book (1861, p. 227) an occupational clinical picture of mercurial 
intoxication in miners. Among the symptoms of eretism-increased irritability, he also mentions 
“restless sleep, terrible dreams and frighten awakenings”.  
Our observations are based on data collected from the program of health surveillance of 
workers exposed to Hg in the Idrija Mercury Mine. In the first 20 years following the 
Second World War, the number of Hg intoxicated workers was very high (ranging from 10 
to 14% of workers in the mine and smelting plant). After 1975, no new cases of intoxication 
were observed thanks to the introduction of preventive-target medical examinations, which, 
after 1968, also included biological monitoring of exposure. Subjective descriptions of sleep 
disturbances and other potential, known, subjective troubles associated with Hg exposure 
were always evaluated directly by the physician during contact with intoxicated or exposed 
workers in the course of preventive target examinations. No polysomnographic recording 
was used to define the stages of sleep in intoxicated workers, or in workers with increased 
Hg absorption. Some disordered sleep, such as fragmentation of sleep accompanied with 
dreaming and awakening, as well as periodic leg contractile movements, were often 
observed as some important early symptoms that announced the critical absorption of Hgº 
vapours in miners working in the pit where native Hg ore was mined, with substantially 
elevated air Hgº vapour levels. During the target medical surveillance and biological 
monitoring of miners intermittently exposed to native Hg, the previously mentioned sleep 
disorder appeared in 30% of exposed miners, associated with increased urinary Hg 
excretion. In these miners, the urine Hg concentrations were usually within a range of 100-
400 g/L, which is, at intermittent type of exposure, associated with blood Hg levels from 
60 to 260 g/L (Kobal, 1975a, 1991), which are substantially above the blood Hg level of  
35 g/L usually accompanied with the earliest nonspecific symptoms (WHO, 1976). In cases 
of subacute mercurialism with classical signs of intoxication, such as stomatitis, limb tremor, 
and other known symptoms and signs, the sleep disorders were much more pronounced, 
and the urinary Hg excretions were very high, in some cases even over 700 g/L (Kobal, 
1975b, 1991). The periodic leg movement index was not evaluated in these miners 
(calculated by dividing the total number of periodic leg movements by sleep time in hours).  
In the cases of increased Hgº absorption, the sleep disorder decreased usually in one to two 
months after the interruption of exposure associated with decreased urine Hg level. In the 
cases of Hgº intoxication, sleep disorders with terrible dreams and and periodic leg 
movements were much more obstinate and disappeared very slowly in association with 
other symptoms and clinical signs of mercurialism; the urine Hg level decreased after 3 to 6 
months. A subclinical  peripheral nerve function with lower motor conduction velocities of 
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the median nerve and lower sensory conduction velocities of the ulnar nerve was observed 
in the subgroup of miners with long-term intermittent exposure and increased Hgº 
absorption (urine Hg excretion > 100g/L). In contrast to sleep disorder, these subclinical 
pripheral nerve function changes usually persist many years after the cessation of exposure 
(Gabrovec-Nahlik et al., 1977; Kobal et al., 2004), which is also in agreement with some other 
observations (Albers et al., 1982). 
As already mentioned above, sleep disorders were also mentioned in the monographs on 
inorganic-elemental mercury published by WHO (1976, 1991) and ATSDR (1999), which place 
them among the symptoms of erethism. However, no disorders of sleep structure or any 
possible neurobiological or biochemical mechanisms and EEG changes that could accompany 
sleep disorders in intoxicated subjects exposed to Hgº are described in these monographs. 
3. The toxicology of elemental mercury-Hg 
3.1 Absorption, disposition in the body, and elimination 
Hg is the only metal that takes the form of liquid at room temperature, and releases 
monoatomic vapours (Hg vapours) that are very stable and may remain in the atmosphere 
for months or even years on end. Their pressure is in equilibrium with the metal, and their 
concentrations attain a value of 18.3 mg/m³ at a room temperature of 24C, which is 360 
times above the “permissible level” for occupational exposure (0.05 mg Hg/m³) prescribed 
in the Environmental Health Criteria 1, Mercury (WHO, 1976). We know today that Hg° 
vapours enter the body mainly through inhalation. As much as 80% of the inhaled amount 
of Hg° is absorbed in the lungs and then passes across the alveolar membrane very quickly 
into the plasma and erythrocytes, and through blood circulation into CNS, kidneys and 
other organs. In the tissue, Hg° oxidizes into the ionic divalent form (Hg++), which takes 
place by way of the hydrogen peroxide-catalase compound I enzyme system. The oxidation 
of Hg° in blood, although rapid, is sufficiently prolonged so that the Hg° dissolved in blood 
can be conveyed to the brain, where it passes the blood-brain barrier and cell membranes. 
Only a small amount of Hg° is oxidized during the transit time from the lungs to the brain, 
so that over ninety percent of dissolved Hg° arrives in the brain unoxidized. It is then 
oxidized in brain cells and complexed to the SH-group of the cell (Hursh et al., 1988; Magos 
et al., 1978). The divalent ionic Hg++ accumulates primarily in astrocytes, where it mostly 
binds to reduced glutathione (GSH), cystein, and metallothioneins (MTs) (Aschner, 1997; 
Tušek-Žnidarič et al., 2007). After Hg° vapour exposure of animals, a marked accumulation 
of Hg was observed in the cerebellum, nucleus olivarius inferior in the brainstem, and in the 
nucleus subtalamicus (Berlin et al., 1969). In autopsy samples of retired and ex-miners 
previously intermittently exposed to Hg°, substantially higher accumulations and retention 
of Hg were observed in the pituitary gland, pineal gland, hippocampus, nucleus dentatus, 
and in the cereballar cortex in comparison with the control group (Falnoga et al., 2000; Kosta 
et al., 1975) (Tab.1). Hg is eliminated in the urine, feces, expired air, sweat, saliva, and milk. 
In long-term occupational exposure, the kidneys are the major pathway of Hg excretion, and 
are not only an indicator of kidney burden, but may also be a rough indicator of total body 
burden. The retention of Hg in the brain observed several years after remote exposure in 
retired mercury miners suggests that the brain does not follow the some kinetics of 
elimination as the kidneys (Falnoga et al., 2000; Kosta et al., 1975; WHO, 1991). In the case of 
intermittent exposure to Hg°, blood Hg was very positively correlated with the spot urine 
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Hg mercury concentration (r=0.68, p < 0.001), which, in such types of exposure, allows use of 
urine Hg as a biological indicator of recent exposure (Kobal, 1991). 
 
 
Table 1. Total Hg concentration in autopsy samples (homogenised tissue) of pituitary gland, 
pineal gland, hippocampus, nucleus dentatus and cereballar cortex (ng/g fresh weight) in 
ex-miners of the Idrija Mercury Mine and controls (data adapted by Falnoga et al., 2000). 
3.2 Toxic effects of Hg 
Various Hg species, as Hg°, methyl-Hg ore ethyl-Hg, accumulates in the central nervous 
system (CNS) and has extremely neurotoxic effects, including the appearance of well-known 
clinical symptoms and signs. In case of occupational exposure to Hg°, the most frequent 
symptoms and signs include “erethism”, increased irritability, depression and other 
neurobehavioral changes, sleep disturbances, oral disturbances, gingivitis and stomatitis with 
excessive salivation, intentional  tremor, peripheral neuropathy (lower sensor and motor 
conduction velocities), and renal impairment. In vitro and in vivo studies showed that Hg can 
stimulate free radical generation as a catalyst in Fenton-type reactions and through some other 
mechanisms, and can promote oxidative stress, peroxidation of lipids and DNA bases, 
disturbances in cell membrane permeation and calcium homeostasis in cells, impairment and 
even apoptosis of monocytes, T cells, glial cells and neurons, disturb the functioning of 
neurotransmitters, and cause immune disorders (Aschner, 2000; ATSDR, 1999; Castoldi et al., 
2001; Clarkson & Magos, 2006; Kobal et al., 2004; Kobal-Grum et al., 2006; Lund et al., 1993; 
Magos, 1997; Pollard & Hultman, 1997; Schara et al., 2001; WHO, 1991).  
3.2.1 Interaction with neurotransmitters 
Various Hg species presynaptically blocks sodium and calcium channels and thus inhibits 
the uptake of some neurotransmitters, especially glutamate into astrocytes, which increases 
their extracellular concentration, thus increasing the sensitivity of neighbouring neurons for 
stimulating excitotoxic effects (Aschner et al., 2007; Brookes, 1996; Castoldi et al., 2001; Sirois & 
Atchison, 1991; Trotti et al., 1997). Many studies reviewed by Mottet et al. in 1997 showed 
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that astrocytes, which accumulate a high level of Hg++, play a fundamental role in 
regulating glutamate level. In cases of methyl-Hg exposure, it seems that the Hg++ ions 
formed after the demethylation of methyl-Hg may also be responsible for the disruption of 
normal Ca++ ion channels. 
Hg may affect sleep because it can: (i) increase extra-cellular glutamate concentrations 
associated with the activation of some cytokines, which can reduce the serotonin level by 
lowering the availability of its precursor, tryptophan, through the activation of its 
metabolizing enzyme, indoleamine 2,3-dioxigenase (McNally et al., 2008); (ii) increase the 
production of nitrogen oxide (NO) (Ikeda et al., 1999), which can directly, or in interaction 
with melatonin, decrease the active form of serotonin (Fossier et al., 1999; Kopczak et al., 
2007); and (iii) Hg can also increase the consumption of serotonin and melatonin because of 
its potential oxidation in interaction with the increased production of free radicals observed 
in microglial cell cultures (Huether et al., 1997; Tan et al., 2000). 
It is suggested that inorganic Hg potentiate and inhibite the neuronal nicotinic acetylcholine 
receptors, depending on its concentration (Mirzoian & Luetje, 2002). Another animal study 
shows that up-regulation of cerebral acetylcholine receptor can occur in chronic methyl-Hg 
exposure to compensate the early stage reduction of brain acetylcholine, as a consequence of 
acetylcholinesterase inhibition (Basu et al., 2006). It is evident from some studies on 
occupationally and environmentally Hg-exposed subjects that Hg enhances the 
dopaminergic effect in CNS, which otherwise leads to cortical hyperexcitability and changes in 
the control of locomotor function, emotions, and behaviour (Burbure et al., 2006; Entezari-
Taher et al., 1999; Lucchini et al., 2003; Missale et al., 1998). 
3.2.2 Subcellular protective mechanism  
Particularly significant in reducing the effects of Hg binding with SH groups of GSH and its 
biochemical precursors, cystine and cysteine, as well as its binding with MTs a cysteine rich 
low molecular weight proteins and with selenium (Se) an essential element and an integral 
part of a type of Se-proteins. The two major thiols, GSH and MTs, appear to be most 
important in regulating the accumulation and detoxification of Hg in CNS. The induction of 
GSH and MTs in astrocytes leads to greater detoxification of Hg and protection of CNS. 
Astrocytes represent the first line of CNS’s defence against Hg (Aschner et al., 2007; Dringen 
et al., 2000). GSH (L--glutamyl-L-cysteinyl-glycine) is synthesized from its precursors, 
glutamate, cysteine and glycine, in the cytosol of cells by the ATP-requiring enzymes -
glutamilcysteine ligase and GSH synthetase (Meister & Andersen, 1983). Most of the free 
intracellular GSH (98%) is in thiol-reduced form (GSH) rather than in disulfide form (GSSG). 
From the cytosol, GSH is delivered into the mitochondria, endoplasmatic reticulum and 
nucleus, but much of it is delivered to extracellular spaces, where its degradation begins to 
occur on the surface of cells that express the enzyme -glutamil transpeptidase. GSH, as a 
nonenzymatic antioxidant, participates in a variety of detoxification, transport, and 
metabolic processes (Ballatri et al., 2009; Rossi et al., 2002). It is speculated that GSH may 
also function as a neuromodulator and neurotransmitter, since the degradation of 
extracellular GSH by -glutamil transpeptidase liberates glutamate and, subsequently, the 
hydrolysis of cysteinylglicine liberates cysteine and glycine, which function as a source of 
neuroactive amino acid (Oja et al., 2000). 
Some other protective mechanisms, such as Se, antioxidative enzymes and melatonin, are 
also important in the detoxification of Hg and its peroxidative effect on the body, and 
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particularly CNS. Se that binds with Hg in CNS in a molecular ratio of 1:1 into a nontoxic 
complex, which in lysosomes represents the last stage of detoxification of Hg (Falnoga et al., 
2002; Kosta et al., 1975;).   
It is evident from the study of ex-mercury miners that the Hg accumulated in the pineal 
gland and bound to Se did not impair its function, while the blood melatonin level was still 
high, probably due to the slow release of Hg from the gland and the adaptive response to 
free radical production induced by Hg (Kobal et al., 2004). Melatonin and free radicals form 
stable secondary and tertiary products, biogene amines, which also enter into reactions with 
free radicals. So melatonin inhibits the excessive formation of NO and its free radicals, 
peroxinitrites, and in this way also reduces the excitotoxic effects of glutamate (Sener et al., 
2003; Tan et al., 2000).  
The main enzymes that provide cellular protection against damage by reactive oxygen 
species mediated by Hg++ are Cu/Zn superoxide dismutase, catalase and the selenoenzyme 
glutathion peroxides, which transform the superoxide anion radical into hydrogen peroxide 
and then into oxygen and water (Lund et al., 1993). It is evident from some studies that 
repeated-intermittent occupational Hg° exposure induced an adaptive response and 
increase of GSH and catalase activity in erythrocytes, as well as the melatonin level in blood. 
The actual levels of GSH and catalase in erythrocytes depend on the actual level of blood 
Hg, both of these decreasing at higher blood Hg concentrations during actual exposure 
(Kobal, 1991; Kobal et al., 2004, 2008).  
4. Some basic neurobiological characteristics of sleep-wake cycles  
A study conducted by Qiu and colleagues in 2010 presented the main overall 
neurobiological activity of basal ganglia neurons associated with the sleep-wake state. The 
differences in firing patterns across the basal ganglia suggest multiple input sources, such as 
the cortex, thalamus, and the dopamine system, as well as some other intra basal ganglia 
inputs, such as the globus pallidus-subtalamic nucleus, and striatum-globus pallidus 
interactions. The largest nucleus striatum of the basal ganglia is mostly comprised  of  -
aminobutiric acid ergic spiny neurons, whose activity is influenced by excitatory 
glutaminergic projection from the neocortex and thalamus, and dopaminergic projection 
from the midbrain ventral tegmental area and other known parts. The striatum receiving 
cortical inputs projects to the globus pallidus, which then projects to the cerebral cortex 
directly ore by the thalamus (mainly the mediodorsal thalamic nucleus). It was suggested 
that the lesion of globus pallidus produced a higher increase in wakefulness and frequent 
sleep-wake transitions, as well as a concomitant decrease in non-REM sleep duration. The 
results of the study also suggest that the cortico-striato-pallidal loop may be critically 
involved in the basal ganglia control of arousal. 
There are four stages of sleep, which include the brain-active period associated with rapid 
eye movements called REM sleep (emergent stage 1 EEG), preceded by progressively deeper 
sleep stages (stages 2, 3, 4) graded on the basis of increasingly slower EEG patterns, called 
non-REM sleep. Stages 3 and 4 are referred to as slow-wave sleep (SWS) characterized by 
delta waves (high amplitude and low-frequency). REM sleep and wakefulness are 
characterized by increased activity in the cerebral cortex with low-amplitude and high-
frequency EEG (alpha waves) and in REM by the inhibition of peripheral neurons displayed 
in the postural muscle atonia. Increased cerebral activity during REM sleep is associated 
with higher oxygen consumption, blood flow and neural firing (Madsen et al., 1991). 
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Acetylcholine, norepinephrine, serotonin, histamine and hypocretin levels are increased in 
wakefulness and low in non-REM sleep, whereas during REM sleep the noradrenergic, 
serotonergic and histaminergic cells become silent (Jones, 2005). A high cholinergic tone in 
the pontine reticular formation combined with a low GABAergic tone contributes to the 
generation of REM sleep (Vanini et al., 2011). Animal studies showed that the 
neurotransmitter glutamate enhances REM sleep by activation of the kainite receptor within 
the cholinergic cell compartment of the brainstem pedunculo pontine tegmentum of cat and 
rat (Datta, 2002). During REM sleep and waking, the release of acetylcholine activated 
dopamine in the ventral tegmental neurons, which were higher in the prefrontal cortex and 
nucleus accumbens. It was also suggested that glutamate and asparate release can 
reciprocally affect dopamine release (Forster and Blaha, 2000; Morari et al., 1998). The 
animal study of Lena and colleagues in 2005 also showed elevated levels of dopamine 
during waking and REM sleep in the medial prefrontal cortex and nucleus accumbens.  
The impairment of the subcortical dopaminergic system may cause disinhibition of the 
GABAergic inhibitory circuitry at the motor cortex level (Entazry-Taher et al., 1999; 
Ziemann et al., 1996). It is suggested that the diencephalon-spinal dopaminergic tract could 
be important as a potential anatomic site of dopaminergic dysfunction in restless leg 
syndrome, and of periodic leg contractile movements in sleep. The diencephalon-spinal 
dopaminergic tract projects to the limbic system, sensory cortex and spinal cord (Ondo et al., 
2000). The periodic leg contractile movements occur mainly during non-REM sleep. The 
results of the study of Rijsman et al. in 2005 indicate diminished inhibition at spinal level in 
subjects with periodic leg movements disorder, probably because of the altered function of 
the descending spinal tracts and peripheral changes in the inter-neural circuitry at the spinal 
level. Dreams and nightmares occur usually at the end of the night, when REM sleep is 
longer. On the other side, sleep terrors occur more often in children than in adults, while 
children have more delta sleep (Pinel, 2009; Lee & Douglass, 2010).  
Another recent animal study (John et al., 2008) showed a rapid increase in the glutamate 
level during REM sleep and awakening in the histamine-containing posterior hypothalamic 
region and the perifornical-lateral hypothalamus, and its reduction shortly after the 
termination of REM sleep and awakening. In the animal study of Dash and colleagues 
conducted in 2009, which employed a very sensitive method (in vivo amperometry) to 
measure cortical extracellular glutamate, a progressive increase was observed in the cortical 
extracellular glutamate concentration during REM sleep and waking. It was suggested that 
extrasynaptic glutamate is released from astrocytes and neurons in extracellular space, 
where it is accumulated, and then declines during non-REM sleep due to the intracellular re-
uptake mediated by glutamate/asparate transporters. The rate of glutamate decline during 
non-REM sleep positively correlated with the levels of slow wave activity (SWA) (Fig. 1). 
The authors of the study concluded that perhaps the glutamate-decreasing effect of non-
REM sleep is especially relevant in a pathological condition.  
It is thought that the pineal gland itself takes part in regulating the rhythm of sleep and 
wakefulness, entrained by the light/dark cycle. Neural impulses from the retina enter the 
pineal gland, which coordinates the formation and secretion of serotonin and melatonin, 
through the suprachiasmic nuclei (SCN) of the hypothalamus. Light induces serotonin 
secretion, while melatonin is produced at night directly from serotonin by acetylation. 
However, melatonin production can be acutely interrupted by light exposure during the 
night. Norepinephrine, which is released at night in response to stimulatory signals 
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Fig. 1. The rate of glutamate decline during non-REM sleep positively correlated (r = 0.41, p < 
0.01) with the amount of SWA. Each data point represents the average SWA and the change in 
glutamate concentration during non-REM sleep (Adapted from Dash, et al. 2009, The Journal 
of Neuroscience, Vol. 29, No. 3, pp. 620-629. Copyright 2009, Society for Neuroscience. 
Adapted with permission.) 
originating in SCN, also regulates pineal gland activity. Melatonin can influence the sleep-
promoting and sleep-wake rhythm regulating actions through the specific activation of 
melatonin receptors type 1 and 2, which are highly concentrated in SCN, and are also 
expressed in the peripheral organs and cells regulating other physiological functions of the 
so-called circadian 24-hour rhythms. The activation of type 1 occurs by inducing a receptor-
suppressed neuronal firing rate in CNS, while type 2 induces a circadian phase shift. The 
increased secretion of melatonin is also accompanied by other circadian 24-hour rhythms of 
humans, and in rats studies associated with decreased production of  neurotransmitter nitric 
oxide (NO) (Fig. 2) (Dubocovich et al., 2003; Ebadi, 1992; Geoffriau et al., 1998; Leon et al., 
1998; Murphy & Delanty, 2007;  Starc, 1998). Some studies do not confirm the influence of 
melatonin on the duration of sleep (Hughes et al., 1998), while others support the effect of 
melatonin on the duration and quality of REM sleep because they assume that it either 
directly influences cholinergic activity in REM sleep, or indirectly influences REM sleep by 
the elimination of serotonergic or aminergic activity (Jones, 1991; Kunz et al., 2004). It seems 
that melatonin modulates the release of acethylcholine in the nucleus accumbens and the 
motor activity of rats (Paredes et al., 1999). Some animal studies suggest that the daily 
changes in melatonin production may regulate the day-night variation in glutamate and 
GABA in the neostriatum (Marquez de Prado et al., 2000). It seems that the glutaminergic 
system negatively regulates norepinephrine-dependent melatonin synthesis in the rat’s 
pineal gland (Yamada et al., 1998). In rats studies melatonin inhibits the glutamate-mediated 
response of the striatum to motor cortex stimulation and decrease NO content in parieto-
temporal cortex, striatum and brainstem of rats due to the inhibition of neuronal nitric oxide 
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synthase activity. On the other site the administration of high doses of melatonin have 
paradoxal effect and can decrease GABA and increase glutamate levels (Bikjdaouene et al., 
2003; Leon et al., 1998). The synaptically released glutamate is taken up into astrocytes, 
where it is degraded into glutamine by the glutamate-metabolizing enzyme, glutamate 
synthetase. It is suggested that astrocytes are primarily responsible for controlling the 
extracellular level of glutamate, and melatonin seems to have a direct effect on astrocytes 
(Marquez de Prado et al., 2000; Segovia et al., 1999).  
 
 
Fig. 2. Melatonin rhythm acts as an endogenous synchroniser adjusted to the 24-hour 
light/dark cycle, which (rats studies) regulates also the NO production (Adapted from 
Geoffrieau et al., 1998 ; Leon et al., 1998, Hormone Research, Vol. 49, pp. 136-141. Copyright 
1998, S. Karger AG, Medical and Scientific Publishers. Adapted with permission.)  
5. Conclusion 
In the above-mentioned studies, we assumed that the increased uptake of Hgº into  CNS 
could affect sleep: (i) due to the further increase of extracellular concentrations of glutamate, 
which leads to the induction of excitotoxic effects that can have an impact on disbalance of 
cholinergic, glutaminergic and dopaminergic activity and other neuronal activity which 
otherwise regulate non-REM sleep, REM sleep and awakening , and (ii) due to the decreased 
night-time melatonin level, which also seems to be involved in day-night glutamate 
regulation and sleep-wake regulating actions by the activation of melatonin receptors in 
SCN and in the peripheral organ cells regulating other circadian 24-hour rhythms.  
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In vitro and in vivo studies have shown that due to the increased production of free radicals 
as well as blocked sodium and calcium channels, Hg inhibits the uptake of some 
neurotransmitters, especially glutamate, into astrocytes, which increases their extracellular 
concentration, thus increasing the sensitivity of neighbouring neurons for stimulating 
excitotoxic effects (Aschner et al., 2007; Castoldi et al., 2001). The increased production of the 
neurotransmitter nitrogen oxide (NO) mediated by Hg (Ikeda et al., 1999) is also indirectly 
included in the excitotoxic effects of glutamate (Dawson et al., 1991). Hgº thus additionally 
increases the physiological level of extracellular glutamate and its glutaminergic activity 
during REM sleep and awakening. It is not expected that Hg++-mediated glutamate 
accumulation in extracellular space can decline during non-REM-SWA sleep through 
intracellular-astrocyte uptake by glutamate/asparate transporters and its degradation into 
glutamine, whose capacity is satisfactory in physiological conditions (Dash et al., 2009), but 
probably not in Hg++-enhanced glutaminergic activity. It seems that the decrease of 
melatonin mediated by interaction with Hg++ can also decrease the uptake of glutamate in 
astrocytes, which additionally contributes to pathological glutaminergic overactivity at 
increased Hg++ concentrations in CNS.  
Given the results of some animal studies (Lena et al., 2005; Morari et al., 1998) and human 
data (Burbure et al., 2006; Entezari-Taher et al., 1999; Lucchini et al., 2003; Missale et al., 
1998), it is expected that Hg++ enhances the dopaminergic effect in CNS, otherwise 
associated with cortical hyperexcitability and changes in the control of locomotor function. 
The impaired subcortical dopaminergic system, which may cause disinhibition at motor 
cortex level, could be associated with periodic contractile movements of the legs in the sleep 
(Entezari-Taher et al., 1999; Ondo et al., 2000; Rijsman et al., 2005; Ziemann et al., 1996) 
observed in miners during increased Hgº absorption and intoxication. We can not 
completely exclude the potential additive effect of sub-clinical peripheral neuropathy 
observed in miners, which can trigger and modify the appearance of periodic leg contractile 
movements in sleep. 
Melatonin is decreased in the night-time, either because of decreased synthesis under the 
influence of Hg-mediated, increased NO production, which in SCN operates similarly to a 
light signal (Ding et al., 1994; Ikeda et al., 1999), or by lowering its precursor tryptophan 
through its increased metabolizing, and because of its consumption in interaction with free 
radicals (McNally et al., 2008; Sener et al., 2003; Tan et al., 2000). A lower melatonin level is, 
at the same time, associated with the increased production of NO and its free radicals, 
peroxyntrites, which also increase the excitotoxic effects of glutamate (Acuna-Castroviejo et 
al., 1995; Leon et al., 1998). However, it has been established in many studies that melatonin 
plays a role in mediation between the circardian pacemaker and sleep-wake behaviour, and 
may have soporiphic properties and induce sedation, as well as the decreased nocturnal 
melatonin level labilised circadian rhythm function (Rodenbeck & Hajak, 2001; Stone et al., 
2000; Turek & Gillette, 2004). 
Increased extracellular glutamate and its decreased uptake in astrocytes (Dash et al., 2009) 
could hypothetically lead to longer REM periods and more frequent awakening associated 
with more frequent dreaming during increased Hgº absorption or intoxication. 
Hypothetically, persistent glutaminergic activity can also disrupt delta wave sleep, which 
could be associated with the sleep terrors observed in intoxicated miners. Further animal 
studies would be very helpful in elucidating the potential effects of Hg on the uptake of 
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extracellular glutamate into astrocytes during the non-REM sleep, which could be relevant 
for sleep disorders observed in states of increased Hgº absorption or intoxication.  
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